A Pilot, Open-Label, Randomized, Crossover, Pharmacokinetic Study Of Enhanced Bioavailability Formulations Of Celecoxib In Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 03 Mar 2010
At a glance
- Drugs Celecoxib (Primary)
- Indications Ankylosing spondylitis; Gouty arthritis; Juvenile rheumatoid arthritis; Musculoskeletal pain; Osteoarthritis; Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors Pfizer
- 12 Mar 2009 Actual initiation date (Jan 2009) added as reported by ClinicalTrials.gov.
- 12 Mar 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 23 Feb 2009 Planned initiation date changed from 1 Jan 2009 to 1 Feb 2009 as reported by ClinicalTrials.gov.